Altered theophylline pharmacokinetics during acute respiratory viral illness

Lancet. 1978 May 27;1(8074):1132-3. doi: 10.1016/s0140-6736(78)90305-7.

Abstract

The plasma half-life of theophylline was determined during and 1 month after serologically confirmed upper-respiratory-tract viral illness in six children with chronic asthma. In this group the plasma-theophylline half-life (mean = 419.8 min) was significantly longer during the acute stage of their illness than 1 month later (mean 249.9 min). There was no appreciable change in half-life in 4 patients who were febrile but in whom seroconversion did not occur. These preliminary results suggest that certain upper-respiratory-tract viral infections may affect theophylline metabolism.

MeSH terms

  • Acute Disease
  • Adenoviridae Infections / drug therapy*
  • Adenoviridae Infections / metabolism
  • Adenovirus Infections, Human / drug therapy*
  • Adolescent
  • Asthma / complications
  • Asthma / metabolism
  • Child
  • Chronic Disease
  • Female
  • Half-Life
  • Humans
  • Influenza, Human / drug therapy
  • Influenza, Human / metabolism
  • Male
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / metabolism
  • Theophylline / metabolism*
  • Theophylline / therapeutic use

Substances

  • Theophylline